INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.28B -17.4B -9.09B -1.63M -2.25M -1.6M -1.99M -1.25M -2.24M -2.55M -2.77M -2.55M -2.8M -2.77M 97.02K -2.48M -1.82M -2.45M
Depreciation & Amortization
43.85M 87.06M 621.6M 230.5K 230.34K 226.96K 141.6K 20.5K -38.15K 76.95K 77.55K 77.1K -34.82K 72.45K 79.36K 46.42K 31.66K 8.65K
Stock-Based Compensation
623.8M 45M 1.25B 106.33K 1.1M 213.84K 179.53K 265.47K 426.25K 522.24K 412.2K 505.62K 567.9K 738.7K 999.06K 521.32K 619.23K 568.59K
Other Working Capital
n/a n/a 322.89K 134.76K -308.94K -148.71K -23.31K -543.09K 93.88K 83.84K 384.66K 42.55K 188.49K -189.75K -3M -52.83K -218.39K -393.5K
Other Non-Cash Items
2.9B 13.73B 4.25B 259.02K 268.62K 843.99K 440.43K 356.16K 167.72K 251.12K 219.05K 66.47K 92.2K 71.12K 173.35K 77.82K 76.98K 860.15K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -6.32K 8.16K -3.79K n/a 810.00 n/a n/a n/a 214.05K 111.99K -157.62K n/a
Change in Working Capital
n/a n/a 130.43K 394.01K -809.55K 285.11K 524.67K -649.17K 44.08K 552.12K 1.05M 252.17K 247.68K -186.07K -3.07M 114.11K 73.17K -719.31K
Operating Cash Flow
-1.72B -3.55B -2.97B -640.81K -1.46M -260.56K -714.88K -1.25M -1.64M -1.15M -1M -1.65M -1.87M -2.08M -1.51M -1.61M -1.17M -1.74M
Capital Expenditures
n/a n/a n/a 104.83K -55.13K -49.7K -75K -108.22K -261.5K n/a 135.00 -3.01K -3.29K -6.56K -414.96K -747.41K -6.4K -28.98K
Cash Acquisitions
n/a n/a 75.59K -75.59K -25.59K 25.59K 108.29K -2.15M n/a -8.45K 8.45K n/a -1.61K -75.33K -1.45M 627.12K -880K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a 8.45K n/a n/a -8.45K 8.45K n/a -1.61K -75.33K -1.45M -252.88K n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a 2.49M n/a n/a n/a -16.9K n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-15.45M -14.65M 393.06M -29.24M 50K -24.11K -2.5M n/a n/a 8.45K 8.45K -426 -2.22K -76.24K 943.1K 427.12K -600K -280K
Investing Cash Flow
-15.45M -14.65M 393.13M -29.21M -5.13K -24.11K 33.29K -2.26M -261.5K -8.45K 8.58K -3.01K -4.9K -81.89K -917.84K -320.29K -606.4K -308.98K
Debt Repayment
n/a n/a 84.22K 31.96K -143.55K 27.37K -141.53K 1.45M -190.15K 544K n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-305.25M -305.25M n/a -250.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.75B 3.96B 2.95B 250.63M 900.61K 500K 23.05K n/a n/a 2.71M 800K n/a n/a n/a 3.4M n/a n/a 369.84K
Financial Cash Flow
1.44B 3.66B 3.12B 169.46K 1.93M 527.37K -141.53K 4.45M -169.86K 3.26M 800K -25.2K n/a 315K 3.4M n/a n/a 369.84K
Net Cash Flow
-291.23M 99.01M 740.92M -471.34K 467.81K 242.7K -823.12K 943.06K -2.08M 2.1M -195.56K -1.68M -1.88M -1.85M 971.75K -1.93M -1.78M -1.67M
Free Cash Flow
-1.72B -3.55B -2.97B -2.36B -1.51M -310.25K -789.88K -1.36M -1.91M -1.15M -1M -1.65M -1.88M -2.08M -1.93M -2.36M -1.18M -1.76M